FAKTOR-OPTIONSSCHEIN - INCYTE CO. Stock

DE000SQ8HCD7

Market Closed - Deutsche Boerse AG 15:46:05 2024-05-24 EDT
26.26 ^EUR	+3.02%

Current month	-48.71%
1 month	-50.11%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	05-23	MT
Incyte Acquires 2 Office Buildings in Delaware	05-21	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	05-21	BU
Incyte to Present at Upcoming Investor Conference	05-21	BU

More news

Quotes 5-day view

Date	Price	Change
24-05-24	26.26	+3.02%
24-05-23	25.49	+4.30%
24-05-22	24.44	-6.29%
24-05-21	26.08	-2.40%
24-05-20	26.72	+0.83%

Delayed Quote Deutsche Boerse AG

Last update May 24, 2024 at 03:46 pm

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SQ8HCD
ISIN	DE000SQ8HCD7
Date issued	2023-02-01
Strike	83.68 $
Maturity	Unlimited
Parity	1 : 1
Emission price	10.22 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	86.57 €
Lowest since issue	9.33 €
Spread	0.15 €
Spread %	0.57%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.31 USD

Average target price

72.8 USD

Spread / Average Target

+27.03%

Consensus